Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation

BACKGROUND: The development of accurate urinary biomarkers for non-invasive and cost-effective detection of primary and recurrent bladder tumours is recognized as one of the major clinical needs in bladder cancer diagnostics. The purposes of this study were (1) to validate the results of a previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Hentschel, Anouk E., Beijert, Irene J., Bosschieter, Judith, Kauer, Paul C., Vis, André N., Lissenberg-Witte, Birgit I., van Moorselaar, R. Jeroen A., Steenbergen, Renske D. M., Nieuwenhuijzen, Jakko A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818199/
https://www.ncbi.nlm.nih.gov/pubmed/35123558
http://dx.doi.org/10.1186/s13148-022-01240-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818199/
https://www.ncbi.nlm.nih.gov/pubmed/35123558
http://dx.doi.org/10.1186/s13148-022-01240-8

Ejemplares similares